Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin for Brain Mechanisms in Opioid Use Disorder
NCT06810310Phase 2Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Dec 2025
- Primary completion
- May 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in opioid use disorder (OUD), sponsored by University of Pennsylvania. Started Dec 2025; status: recruiting.
02
Drugs
psilocybin
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06810310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06810310.